Page last updated: 2024-11-11

3-dehydroshikimate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-dehydroshikimate : A monocarboxylic acid anion that is the conjugate base of 3-dehydroshikimic acid, arising from deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

3-dehydroshikimic acid : A 4-oxo monocarboxylic acid that is shikimic acid in which the allylic hydroxy group has been oxidised to the corresponding keto group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5460360
CHEBI ID16630
MeSH IDM0253612

Synonyms (7)

Synonym
(4s,5r)-4,5-dihydroxy-3-oxocyclohex-1-ene-1-carboxylate
CHEBI:16630 ,
3-dehydroshikimate
5-dehydroshikimic acid
3-dehydroshikimic acid
(4s,5r)-4,5-dihydroxy-3-oxocyclohexene-1-carboxylate
Q61014520
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
monocarboxylic acid anionA carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (27)

PathwayProteinsCompounds
Chorismate Biosynthesis1017
Secondary Metabolites: Shikimate Pathway811
Shikimate Pathway (Chorismate Biosynthesis)716
gallate biosynthesis17
chorismate biosynthesis from 3-dehydroquinate014
chorismate biosynthesis I418
Mycobacterium tuberculosis biological processes3962
Chorismate via Shikimate Pathway721
superpathway of L-phenylalanine biosynthesis1665
superpathway of aromatic compound degradation via 2-hydroxypentadienoate5095
superpathway of aromatic compound degradation via 3-oxoadipate3681
superpathway of aromatic amino acid biosynthesis2184
chorismate biosynthesis I1559
chorismate biosynthesis from 3-dehydroquinate1037
chorismate biosynthesis II (archaea)930
superpathway of L-tyrosine biosynthesis1557
superpathway of chorismate metabolism56186
quinate degradation II69
quinate degradation I46
superpathway of L-tryptophan biosynthesis1665
shikimate degradation I25
shikimate degradation II27
gallate biosynthesis213
superpathway of phenylalanine, tyrosine and tryptophan biosynthesis1336
chorismate biosynthesis416
superpathway of phenylalanine, tyrosine, and tryptophan biosynthesis038
superpathway of tryptophan biosynthesis030
superpathway of tyrosine biosynthesis024
superpathway of phenylalanine biosynthesis022
superpathway of chorismate576
superpathway of aromatic compound degradation3349

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (8.57)18.2507
2000's14 (40.00)29.6817
2010's16 (45.71)24.3611
2020's2 (5.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.28 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index38.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]